People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Pharmaceuticals, Other, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cortexyme, Inc. | — | Pharmaceuticals | Series C | $111.5M | $71.9M | 2025 |
| Elemental Machines, Inc. | — | Other | Series C | $44.1M | $451.0M | 2022 |
| Bioarray Genetics, Inc. | — | Other Health Care | Series A | $6.7M | $105.3M | 2015 |
| Iquum Inc | — | Biotechnology | Pre-Seed | $1.0M | $55.2M | 2010 |
Una Ryan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Una Ryan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Davoli | 1 | 22 |
| Patrick O'Neill | 1 | 14 |
| Sonny Vu | 1 | 7 |
| Ilan Zipkin | 1 | 6 |
| Pauline Murphy | 1 | 6 |
| Jeff Klemens | 1 | 5 |
| Zafrira Avnur | 1 | 4 |
| Casey Lynch | 1 | 4 |
| David Taft | 1 | 3 |
| Henry Kay | 1 | 3 |
| Keith Greenfield | 1 | 3 |
| Gaurav Tewari | 1 | 3 |
| Dirk Thye | 1 | 3 |
| Charles Ryan | 1 | 3 |
| Margi McLoughlin | 1 | 2 |
| Sridhar Iyengar | 1 | 2 |
| Roger Quy | 1 | 2 |
| Pamela Layton | 1 | 2 |
| Kristen Gafric | 1 | 1 |
| Stephen Dominy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.